不同血液透析液生物相容性的研究进展  

Biocompatibility Research Progresses of Different Kind of Hemodialysate

作　　者：蔡伶伶[1] 金惠敏[1] 

机构地区：[1]上海交通大学医学院附属第三人民医院肾脏内科,上海201900

出　　处：《医学综述》2011年第5期715-718,共4页Medical Recapitulate

摘　　要：血液透析在提高慢性肾衰竭患者生存率的同时,也因其出现的脂质代谢紊乱、微炎症状态和营养不良,导致多种远期并发症,严重影响患者的生存时间。近年来,研究发现使用超纯血液透析液可以改善患者的脂质代谢、炎症水平和营养不良等,血液透析液的纯度与血透质量密切相关。现就国内外不同纯度血透液对慢性肾衰竭患者血脂代谢、炎症水平及营养等研究进展进行综述。While improving the survival rate of patients with chronic renal failure,hemodialysis also leads to dislipidemia,micro-inflammation and malnutrition,resulting in a variety of long-term complications,which seriously reduce the patients′ survival time.Recently studies have revealed that using ultrapure dialysis fluid could improve the complications of patients′ such as lipid metabolism,inflammation and malnutrition etc.The purity of hemodialysis fluid is closely related with the quality of hemodialysis.The research progress at home and abroad of dislipidemia,inflammation and malnutrition of patients who using different purity of hemodialysate aer reviewed in this paper.

关 键 词：常规血液透析液 超纯血液透析液 高纯血液透析液 微炎症 营养不良 血脂异常 

分 类 号：R459.5[医药卫生—治疗学]